Across spinal cord injury, stroke-related brain damage, and Parkinson’s disease, researchers are looking for better ways to understand what is happening in the nervous system before, during, and after injury. One paper highlights the growing role of fluid-based biomarkers in spinal cord injury, showing how measurable signals in the body could help estimate injury severity, predict recovery, guide treatment dosing, and improve clinical trials. This matters because better tracking tools could help move spinal cord injury care toward more personalized and precise therapy.
The other two studies focus on mechanisms of damage and protection in the brain. Eupalinolide B was shown to reduce oxidative stress, inflammation, mitochondrial damage, and neuron loss after cerebral ischemia-reperfusion injury, with effects tied to PI3K/Akt/GSK3β signaling. Meanwhile, spatial lipidomics revealed how α-synuclein may disrupt important lipid patterns in Parkinsonian mice, especially in brain regions central to movement. Together, these studies point to a larger shift in neuroscience: combining biomarkers, molecular targets, and tissue-level mapping to better understand injury, degeneration, and repair.
1. Evolving role of biomarkers in spinal cord injury: From research to clinical translation
Fluid-based biomarkers may help track spinal cord injury severity, predict recovery, guide dosing, and improve clinical trial design. Integrating multi-biomarker panels with AI could accelerate more precise, personalized SCI therapies.
2. Eupalinolide B prevents cerebral ischemia-reperfusion injury via the PI3K/Akt/GSK3β(Ser9) signaling pathway
Eupalinolide B protected against cerebral ischemia-reperfusion injury by reducing oxidative stress, mitochondrial damage, inflammation, and neuronal apoptosis. Its effects were linked to activation of the PI3K/Akt/GSK3β signaling pathway in cell and mouse models.
3. Spatial lipidomics identifies α-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model
Spatial lipidomics revealed that α-synuclein overexpression disrupts key brain lipids in Parkinsonian mice, especially in the substantia nigra and striatum. These changes involved sphingolipids, oxidized lipids, and membrane-related lipid patterns that may contribute to α-synuclein toxicity.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
